Through the Qualifying, Testing, Issuing (QTI) Project, FHI 360 implements a comprehensive, risk-based quality assurance program to ensure that health commodities procured on behalf of the U.S. Department of State are safe, effective, and quality for clients and patients.
The project includes:
- Conducting product risk assessments
- Qualifying suppliers of health commodities
- Performing audits and evaluations of suppliers
- Managing supplier and product eligibility lists
- Overseeing product quality incidents and recalls
- Conducting quality control sampling, testing, and analysis
Through these quality assurance and quality control objectives, FHI 360 enables access to quality-assured health products—including pharmaceuticals, medical devices, in vitro diagnostics, and vector control commodities—that support the Department of State’s health programs.
QTI maintains lists of products and suppliers that are eligible for procurement. The public version of the list of eligible products and suppliers can be accessed here.